FDA
- Status: approved
Oral bifidobacterium triple live powder (Oral bifidobacterium triple live powder) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Zhuhai Center for Maternal and Child Health Care is the originator. The local marketing authorisation holder may differ — check the official source linked above.